{
    "mtblsStudy": {
        "studyStatus": "Public",
        "curationRequest": "MANUAL_CURATION",
        "modifiedTime": "2024-05-23T00:00:00",
        "statusUpdateTime": "2024-05-23T15:29:48.810429",
        "read_access": true,
        "write_access": false,
        "is_curator": false
    },
    "isaInvestigation": {
        "comments": [
            {
                "name": "Created With Configuration",
                "value": "MetaboLightsConfig20150707"
            },
            {
                "name": "Last Opened With Configuration",
                "value": "MetaboLightsConfig20150707"
            }
        ],
        "identifier": "MTBLS9677",
        "title": "X chromosome dosage drives statin-induced dysglycemia and mitochondrial dysfunction",
        "description": "Created using the MetaboLights Online Editor (MOE)",
        "submissionDate": "04/03/2024",
        "publicReleaseDate": "2024-05-23",
        "filename": "",
        "people": [],
        "publications": [],
        "ontologySourceReferences": [
            {
                "comments": [],
                "name": "OBI",
                "file": "http://data.bioontology.org/ontologies/OBI",
                "version": "29",
                "description": "Ontology for Biomedical Investigations"
            },
            {
                "comments": [],
                "name": "MTBLS",
                "file": "https://www.ebi.ac.uk/metabolights/",
                "version": "1",
                "description": "User defined terms"
            },
            {
                "comments": [],
                "name": "NCIT",
                "file": "",
                "version": "",
                "description": ""
            },
            {
                "comments": [],
                "name": "EFO",
                "file": "http://data.bioontology.org/ontologies/EFO",
                "version": "132",
                "description": "Experimental Factor Ontology"
            },
            {
                "comments": [],
                "name": "CHEBI",
                "file": "",
                "version": "",
                "description": ""
            },
            {
                "comments": [],
                "name": "GO",
                "file": "",
                "version": "",
                "description": ""
            },
            {
                "comments": [],
                "name": "CHMO",
                "file": "",
                "version": "",
                "description": ""
            },
            {
                "comments": [],
                "name": "HP",
                "file": "",
                "version": "",
                "description": ""
            }
        ],
        "studies": [
            {
                "comments": [],
                "identifier": "MTBLS9677",
                "filename": "s_MTBLS9677.txt",
                "title": "X chromosome dosage drives statin-induced dysglycemia and mitochondrial dysfunction",
                "description": "<p>Statin drugs lower blood cholesterol levels for cardiovascular disease prevention. Women are more likely than men to experience adverse statin effects, particularly new-onset diabetes (NOD) and muscle weakness. Here we find that impaired glucose homeostasis and muscle weakness in statin-treated female mice are associated with reduced levels of the omega-3 fatty acid, docosahexaenoic acid (DHA), impaired redox tone, and reduced mitochondrial respiration. Statin adverse effects are prevented in females by administering fish oil as a source of DHA, by reducing dosage of the X chromosome or the Kdm5c gene, which escapes X chromosome inactivation and is normally expressed at higher levels in females than males. As seen in female mice, we find that women experience more severe reductions than men in DHA levels after statin administration, and that DHA levels are inversely correlated with glucose levels. Furthermore, induced pluripotent stem cells from women who developed NOD exhibit impaired mitochondrial function when treated with statin, whereas cells from men do not. These studies identify X chromosome dosage as a genetic risk factor for statin adverse effects and suggest DHA supplementation as a preventive co-therapy.&nbsp;</p>",
                "submissionDate": "04/03/2024",
                "publicReleaseDate": "2024-05-23",
                "people": [
                    {
                        "comments": [],
                        "firstName": "Nomura",
                        "lastName": "Daniel",
                        "email": "dnomura@berkeley.edu",
                        "affiliation": "University of California, Berkeley",
                        "address": "2151 Berkeley Way, Room 312G, Berkeley, CA 94720",
                        "fax": "",
                        "midInitials": "K",
                        "phone": "5106437258",
                        "roles": [
                            {
                                "comments": [],
                                "annotationValue": "Collaborator",
                                "termSource": {
                                    "comments": [],
                                    "name": "NCIT",
                                    "file": "",
                                    "version": "",
                                    "description": ""
                                },
                                "termAccession": "http://purl.obolibrary.org/obo/NCIT_C84336"
                            }
                        ]
                    }
                ],
                "studyDesignDescriptors": [
                    {
                        "comments": [],
                        "annotationValue": "Lipidomics",
                        "termSource": {
                            "comments": [],
                            "name": "NCIT",
                            "file": "",
                            "version": "",
                            "description": ""
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/NCIT_C153193"
                    },
                    {
                        "comments": [],
                        "annotationValue": "statin",
                        "termSource": {
                            "comments": [],
                            "name": "CHEBI",
                            "file": "",
                            "version": "",
                            "description": ""
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/CHEBI_87631"
                    },
                    {
                        "comments": [],
                        "annotationValue": "docosahexaenoic acid",
                        "termSource": {
                            "comments": [],
                            "name": "CHEBI",
                            "file": "",
                            "version": "",
                            "description": ""
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/CHEBI_36005"
                    },
                    {
                        "comments": [],
                        "annotationValue": "X chromosome",
                        "termSource": {
                            "comments": [],
                            "name": "GO",
                            "file": "",
                            "version": "",
                            "description": ""
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/GO_0000805"
                    },
                    {
                        "comments": [],
                        "annotationValue": "KDM5C Gene",
                        "termSource": {
                            "comments": [],
                            "name": "NCIT",
                            "file": "",
                            "version": "",
                            "description": ""
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/NCIT_C97598"
                    },
                    {
                        "comments": [],
                        "annotationValue": "biomarker",
                        "termSource": {
                            "comments": [],
                            "name": "CHEBI",
                            "file": "",
                            "version": "",
                            "description": ""
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/CHEBI_59163"
                    },
                    {
                        "comments": [],
                        "annotationValue": "Glucose intolerance",
                        "termSource": {
                            "comments": [],
                            "name": "HP",
                            "file": "",
                            "version": "",
                            "description": ""
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/HP_0001952"
                    },
                    {
                        "comments": [],
                        "annotationValue": "ultra-performance liquid chromatography-mass spectrometry",
                        "termSource": {
                            "comments": [],
                            "name": "CHMO",
                            "file": "",
                            "version": "",
                            "description": ""
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/CHMO_0000715"
                    },
                    {
                        "comments": [],
                        "annotationValue": "tandem mass spectrometry",
                        "termSource": {
                            "comments": [],
                            "name": "CHMO",
                            "file": "",
                            "version": "",
                            "description": ""
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/CHMO_0000575"
                    },
                    {
                        "comments": [],
                        "annotationValue": "untargeted metabolites",
                        "termSource": {
                            "comments": [],
                            "name": "MTBLS",
                            "file": "https://www.ebi.ac.uk/metabolights/",
                            "version": "1",
                            "description": "User defined terms"
                        },
                        "termAccession": "http://www.ebi.ac.uk/metabolights/ontology/MTBLS_000279"
                    }
                ],
                "publications": [
                    {
                        "comments": [],
                        "title": "X chromosome dosage drives statin-induced dysglycemia and mitochondrial dysfunction",
                        "authorList": "Zhang Peixiang, Munier Joseph J., Wiese Carrie B., Vergnes Laurent, Link Jenny C., Abbasi Fahim, Ronquillo Emilio, Scheker Katherine, Mu\u00f1oz Antonio, Kuang Yu-Lin, Theusch Elizabeth, Lu Meng, Sanchez Gabriela, Oni-Orisan Akinyemi, Iribarren Carlos, McPhaul Michael J., Nomura Daniel K., Knowles Joshua W., Krauss Ronald M., Medina Marisa W., Reue Karen",
                        "pubMedID": "38956041",
                        "doi": "10.1038/s41467-024-49764-2",
                        "status": {
                            "comments": [],
                            "annotationValue": "Published",
                            "termSource": {
                                "comments": [],
                                "name": "EFO",
                                "file": "http://data.bioontology.org/ontologies/EFO",
                                "version": "132",
                                "description": "Experimental Factor Ontology"
                            },
                            "termAccession": "http://www.ebi.ac.uk/efo/EFO_0001796"
                        }
                    }
                ],
                "factors": [
                    {
                        "comments": [],
                        "factorName": "treatment",
                        "factorType": {
                            "comments": [],
                            "annotationValue": "treatment",
                            "termSource": {
                                "comments": [],
                                "name": "EFO",
                                "file": "http://data.bioontology.org/ontologies/EFO",
                                "version": "132",
                                "description": "Experimental Factor Ontology"
                            },
                            "termAccession": "http://www.ebi.ac.uk/efo/EFO_0000727"
                        }
                    }
                ],
                "protocols": [
                    {
                        "comments": [],
                        "name": "Sample collection",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Sample collection",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>Animal studies were performed under approval from the UCLA Institutional Animal Care and Use Committee (protocol ARC 2006-161).&nbsp;Male <strong>C57BL/6J mice</strong> were obtained from The Jackson Laboratory (Bar Harbor, ME). Mice were maintained at ambient temperature on a 12 h light/dark cycle with an ambient temperature of 21\u201322 \u00b0C and humidity of 50\u201360%.</p><p><br></p><p>From weaning, all mice were maintained on standard mouse chow. At 8\u00ad\u00ad\u201310 wk, mouse cohorts were divided into animals receiving<strong> chow diet </strong>alone (diet D1001 containing 10 kcal% fat, 20 kcal% protein and 70 kcal% carbohydrate; Research Diets, New Brunswick, NJ) or the identical chow containing <strong>simvastatin </strong>or<strong> atorvastatin</strong>, (0.1 g/Kg food weight in mouse chow, formulation D11060903i, Research Diets), and livers were removed and flash frozen until analysis. A simvastatin dose of 0.1g/Kg in mouse is similar to 80 mg/d in humans based on the FDA conversion factor of 12.3 for \u201chuman equivalent dose\u201d in a mouse. Thus, 80 mg per 60 Kg human= 1.3 mg/Kg. A dose of 0.1 mg/g (i.e., 0.1 g/Kg) for a 25 g mouse that eats 4 g per day= 0.4 mg/25 g body weight= 16 mg/Kg. Finally, 16 mg/Kg/12.3 (FDA conversion factor)= 1.3 mg/Kg.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Extraction",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Extraction",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>Non-polar lipid metabolites were quantified in mouse liver as previously described<strong>[1]</strong>. Livers were extracted in chloroform:methanol:PBS with inclusion of internal standards C12:0 dodecylglycerol (10 nmol) and penta-decanoic acid (10 nmol). Organic and aqueous layers were separated, and the aqueous layer was acidified, for detection of metabolites such as lysophosphatidic acid (LPA) and LPA-ether (LPAe), followed by re-extraction with chloroform. The organic layers were combined, dried down, and analyzed by both single-reaction monitoring (SRM)-based <strong>LC-MS/MS</strong> as previously described<strong>[1]</strong>.</p><p><br></p><p><strong>Ref:</strong></p><p><strong>[1]</strong> Benjamin, D.I., Cozzo, A., Ji, X., Roberts, L.S., Louie, S.M., Mulvihill, M.M., Luo, K., Nomura, D.K. Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity. Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):14912-7. doi:10.1073/pnas.1310894110. PMID: 23980144. PMCID: PMC3773741.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Post Extraction",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Derivatization",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Chromatography",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Chromatography",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>Metabolite separation was achieved with an <strong>Agilent 1260 Infinity LC</strong> and a<strong> Luna C5 100 \u00c5 (5 \u00b5m, 4.6 mm x 50 mm; Phenomenex) </strong>column. Mobile phase A was water:methanol (95:5, v:v) and mobile phase B consisted of isopropanol, methanol, and water (60:35:5, v:v:v). Solvent modifiers 0.1% formic acid with 5 mM ammonium formate and 0.1% ammonium hydroxide were used to assist ion formation and to improve the LC resolution in both positive and negative ionization modes, respectively. The flow rate for each run started at 0.1 mL/min for 5 min to alleviate back pressure associated with injecting chloroform. The gradient started at 0% B and increased linearly to 100% B over the course of 45 min with a flow rate of 0.4 mL/min, followed by an isocratic gradient of 100% B for 17 min at 0.5 mL/min, before equilibrating for 8 min at 0% B with a flow rate of 0.5 mL/min.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Chromatography Instrument",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Autosampler model",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Column model",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Column type",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Guard column",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Mass spectrometry",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Mass spectrometry",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>MS analysis was performed with an electrospray ionization (ESI) source on an <strong>Agilent 6430 Triple Quadrupole</strong>. The capillary voltage was set to 3.0 kV, and the fragmentor voltage was set to 100 V. The drying gas temperature was 350 \u00b0C, the drying gas flow rate was 10 L/min, and the nebulizer pressure was 35 psi. Representative metabolites were quantified by SRM of the transition from precursor to product ions at associated optimized collision energies. Mass range was <strong>50-1200 m/z</strong>.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Scan polarity",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Scan m/z range",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Instrument",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Ion source",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Mass analyzer",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Data transformation",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Data transformation",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>Data were exported as mzdata files and uploaded to <strong>XCMS Online</strong> (<a href='https://xcmsonline.scripps.edu/' rel='noopener noreferrer' target='_blank'>xcmsserver.nutr.berkeley.edu</a>) to identify metabolites that were differentially changed<strong>[1]</strong>. These metabolites from untargeted analysis were putatively identified through using the <a href='https://metlin.scripps.edu/' rel='noopener noreferrer' target='_blank'><strong>METLIN</strong></a> online database<strong>[2]</strong>.</p><p><br></p><p><strong>Refs:</strong></p><p><strong>[1] </strong>Tautenhahn, R., Patti, G.J., Rinehart, D., Siuzdak, G. 2012. XCMS Online: A web-based platform to process untargeted metabolomic data. Anal. Chem.&nbsp;2012, 84, 11, 5035\u20135039. doi:10.1021/ac300698c. PMID:&nbsp;22533540. PMCID:&nbsp;PMC3703953.</p><p><strong>[2] </strong>Tautenhahn, R., Cho, K., Uritboonthai, W., Zhu, Z., Patti, G.J. and Siuzdak, G., 2012. An accelerated workflow for untargeted metabolomics using the METLIN database.&nbsp;Nature biotechnology,&nbsp;30(9), pp.826-828. doi:10.1038/nbt.2348. PMID:&nbsp;22965049.&nbsp;PMCID:&nbsp;PMC3666346.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Metabolite identification",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Metabolite identification",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>Standards were purchased to confirm coelution and fragmentation of the standard with the metabolite of interest. These metabolites were then quantified by SRM analysis, integrating the area under the peak and were normalized to internal standard values and then levels from statin-treated animals were expressed as relative levels compared with control animals.&nbsp;</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    }
                ],
                "assays": [
                    {
                        "comments": [],
                        "measurementType": {
                            "comments": [],
                            "annotationValue": "metabolite profiling",
                            "termSource": {
                                "comments": [],
                                "name": "OBI",
                                "file": "http://data.bioontology.org/ontologies/OBI",
                                "version": "29",
                                "description": "Ontology for Biomedical Investigations"
                            },
                            "termAccession": "http://purl.obolibrary.org/obo/OBI_0000366"
                        },
                        "technologyType": {
                            "comments": [],
                            "annotationValue": "mass spectrometry",
                            "termSource": {
                                "comments": [],
                                "name": "OBI",
                                "file": "http://data.bioontology.org/ontologies/OBI",
                                "version": "29",
                                "description": "Ontology for Biomedical Investigations"
                            },
                            "termAccession": "http://purl.obolibrary.org/obo/OBI_0000470"
                        },
                        "technologyPlatform": "Liquid Chromatography MS - positive - reverse phase",
                        "filename": "a_MTBLS9677_LC-MS_liver_positive_reverse-phase_metabolite_profiling.txt",
                        "dataFiles": [],
                        "processSequence": [],
                        "sources": [],
                        "samples": [],
                        "otherMaterials": [],
                        "characteristicCategories": [],
                        "units": [],
                        "graph": null
                    }
                ],
                "sources": [],
                "samples": [],
                "processSequence": [],
                "characteristicCategories": [],
                "units": []
            }
        ]
    },
    "validation": {
        "errors": [],
        "warnings": []
    }
}